Literature DB >> 14719586

HLA genotyping in type-I autoimmune hepatitis in Western India.

D N Amarapurkar1, N D Patel, Anjali D Amarapurkar, S R Kankonkar.   

Abstract

OBJECTIVES: To analyze association of different HLA genotypes for predisposition to type-I autoimmune hepatitis in Western India.
METHODS: This study was undertaken on patients of type-I autoimmune hepatitis (defined by international criteria by IAHG, 1999). HLA genotyping for class I and II was done in 20 patients of autoimmune hepatitis and 100 healthy controls. Statistics were done using Halden's modification of Woolfs formula. RESULT: Significant association of autoimmune hepatitis was found amongst class I antigens--HLA B27 [20 vs. 0 %] & HLA cw4 [40 vs. 15 %] and amongst class II antigens--DRBI*01XX [25 vs. 2%], DRB1*14XX [30 vs. 12%], DRB1*15XX [40 vs. 25%] and DRB1*07XX [20 vs. 9 %] at DRB1 locus. Stronger association was found with HLA B27, cw4 & HLA DRB1 *01XX.
CONCLUSION: Our data indicate that predisposition to autoimmune hepatitis is different in Indian patients and not associated with HLA DRB1*03XX or *04XX, as seen in Western world.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14719586

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  5 in total

1.  HLA DRB1 Alleles Discriminate the Manifestation of Autoimmune Hepatitis as Type 1 or Type 2 in North Indian Population.

Authors:  Navchetan Kaur; Ranjana W Minz; Shashi Anand; Biman Saikia; Ritu Aggarwal; Ashim Das; Babu R Thapa; Yogesh K Chawla
Journal:  J Clin Exp Hepatol       Date:  2013-12-16

2.  The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis.

Authors:  Guiqiang Wang; Atsushi Tanaka; Hong Zhao; Jidong Jia; Xiong Ma; Kenichi Harada; Fu-Sheng Wang; Lai Wei; Qixia Wang; Ying Sun; Yuan Hong; Huiying Rao; Cumali Efe; George Lau; Diana Payawal; Rino Gani; Keith Lindor; Wasim Jafri; Masao Omata; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-05-04       Impact factor: 6.047

Review 3.  Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events.

Authors:  Esmée P Hoefsmit; Elisa A Rozeman; John B A G Haanen; Christian U Blank
Journal:  ESMO Open       Date:  2019-07-21

Review 4.  Genetic risk factors for autoimmune hepatitis: implications for phenotypic heterogeneity and biomarkers for drug response.

Authors:  Takashi Higuchi; Shomi Oka; Hiroshi Furukawa; Shigeto Tohma; Hiroshi Yatsuhashi; Kiyoshi Migita
Journal:  Hum Genomics       Date:  2021-01-28       Impact factor: 4.639

Review 5.  Recognizing Dysfunctional Innate and Adaptive Immune Responses Contributing to Liver Damage in Patients With Cirrhosis.

Authors:  Ruchika Goel; Chundamannil Eapen Eapen
Journal:  J Clin Exp Hepatol       Date:  2021-10-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.